"Mount Sinai Researchers to Share Theranos Study Data"
After publishing a study evaluating Theranos' medical tests, the researchers are intending to collaborate with the company. “In the coming weeks, we are going to release the full dataset that was the basis of the study. In addition, the software code and statistical code that generated all the figures and results will be put in the public domain,” said co-author of the paper Joel Dudley, PhD, an assistant professor of genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, in response to Theranos’ call for access to the study data. “That’s how good science is done.” Learn more.CNBC
AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model
Jan 04, 2024 View All Press ReleasesDemystifying a Key Receptor in Substance Use and Neuropsychiatric Disorders
Jan 02, 2024 View All Press ReleasesNew Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation
Dec 21, 2023 View All Press Releases